Baidu
map

IDSA 抗微生物革兰氏阴性菌感染治疗指南:2.0 版

2021-11-22 美国感染病学会 IDSA

本文提供了治疗产 AmpC β-内酰胺酶的肠杆菌 (AmpC-E)、耐碳青霉烯类鲍曼不动杆菌(CRAB) 和嗜麦芽窄食单胞菌感染的指南。

中文标题:

IDSA 抗微生物革兰氏阴性菌感染治疗指南:2.0 版

英文标题:

IDSA Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections: Version 2.0

发布机构:

美国感染病学会

发布日期:

2021-11-22

简要介绍:

美国传染病学会 (IDSA) 致力于为耐药性感染的治疗提供最新的指导。先前的指导文件侧重于由产超广谱 β-内酰胺酶的肠杆菌 (ESBL-E)、耐碳青霉烯类肠杆菌 (CRE) 和难治性铜绿假单胞菌 (DTR- . aeruginosa ) 引起的感染。本文提供了治疗产 AmpC β-内酰胺酶的肠杆菌 (AmpC-E)、耐碳青霉烯类鲍曼不动杆菌(CRAB) 和嗜麦芽窄食单胞菌感染的指南。

相关资料下载:
[AttachmentFileName(sort=1, fileName=IDSA 抗微生物革兰氏阴性菌感染治疗指南:2.0 版.pdf)] GetToolGuiderByIdResponse(projectId=1, id=62ea71c0023236d6, title=IDSA 抗微生物革兰氏阴性菌感染治疗指南:2.0 版, enTitle=IDSA Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections: Version 2.0, guiderFrom=IDSA, authorId=0, author=, summary=本文提供了治疗产 AmpC β-内酰胺酶的肠杆菌 (AmpC-E)、耐碳青霉烯类鲍曼不动杆菌(CRAB) 和嗜麦芽窄食单胞菌感染的指南。, cover=https://img.medsci.cn/2022117/1642420763946_1608702.jpg, journalId=0, articlesId=null, associationId=61, associationName=美国感染病学会, associationIntro=美国感染病学会(IDSA)是面向专门从事传染病的医生、科学家和其他医护人员的学会。 核心宗旨是:为临床增加可靠性证据,促进分享以减少传染病给社会带来的经济负担,促进学会成员与其他专业同事之间的合作与交流。, copyright=0, guiderPublishedTime=Mon Nov 22 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #363636;"><span>美国传染病学会 (IDSA) 致力于为耐药性感染的治疗提供最新的指导。</span><span>先前的指导文件侧重于由产超广谱 &beta;-内酰胺酶的肠杆菌 (ESBL-E)、耐碳青霉烯类肠杆菌 (CRE) 和</span><span>难治性铜绿假单胞菌 (DTR-&nbsp;</span></span><em style="color: #363636;"><span>P&nbsp;</span></em><em style="color: #363636;"><span>. aeruginosa</span></em><span style="color: #363636;"><span>&nbsp;) 引起的感染。</span><span>本文提供了治疗产 AmpC &beta;-内酰胺酶的肠杆菌 (AmpC-E)、耐碳青霉烯类</span></span><em style="color: #363636;"><span>鲍曼不动杆菌</span></em><span style="color: #363636;"><span>(CRAB) 和</span></span><em style="color: #363636;"><span>嗜麦芽窄食单胞菌</span></em><span style="color: #363636;"><span>感染的指南。</span></span></p>, tagList=[TagDto(tagId=5481, tagName=革兰氏阴性菌), TagDto(tagId=26540, tagName=细菌组), TagDto(tagId=108159, tagName=革兰氏阴性菌感染)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5103, appHits=114, showAppHits=0, pcHits=814, showPcHits=4986, likes=1, shares=13, comments=6, approvalStatus=1, publishedTime=Mon Jan 17 19:56:04 CST 2022, publishedTimeString=2021-11-22, pcVisible=1, appVisible=1, editorId=0, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Mon Jan 17 20:00:59 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 14:12:05 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=IDSA 抗微生物革兰氏阴性菌感染治疗指南:2.0 版.pdf)])
IDSA 抗微生物革兰氏阴性菌感染治疗指南:2.0 版.pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1196718, encodeId=b4241196e18b5, content=有没有中文版的呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6c5608723, createdName=芳芳要加油呀, createdTime=Thu Feb 24 09:53:25 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194596, encodeId=a4131194596d9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/wXBRnlwuk4va3vboNhiadEuDicEMibKT4WpgCkeG6CLw3kPCm1pqMMRYUZTqTXQzbgcKbaSYsQia2BTZW3U1uYqicGA/132, createdBy=03805115270, createdName=14623ca2m59暂无昵称, createdTime=Thu Feb 17 21:20:23 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185320, encodeId=3b5d118532013, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f94874946, createdName=tyiutyu16, createdTime=Mon Jan 17 20:55:05 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185314, encodeId=92e3118531450, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210729/5d08785c686c4387943d27b2b4a7bf7d/b011876b7af14bacb5649749c0c6192a.jpg, createdBy=6bb05220362, createdName=小括号, createdTime=Mon Jan 17 20:42:41 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-02-24 芳芳要加油呀

    有没有中文版的呀

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1196718, encodeId=b4241196e18b5, content=有没有中文版的呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6c5608723, createdName=芳芳要加油呀, createdTime=Thu Feb 24 09:53:25 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194596, encodeId=a4131194596d9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/wXBRnlwuk4va3vboNhiadEuDicEMibKT4WpgCkeG6CLw3kPCm1pqMMRYUZTqTXQzbgcKbaSYsQia2BTZW3U1uYqicGA/132, createdBy=03805115270, createdName=14623ca2m59暂无昵称, createdTime=Thu Feb 17 21:20:23 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185320, encodeId=3b5d118532013, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f94874946, createdName=tyiutyu16, createdTime=Mon Jan 17 20:55:05 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185314, encodeId=92e3118531450, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210729/5d08785c686c4387943d27b2b4a7bf7d/b011876b7af14bacb5649749c0c6192a.jpg, createdBy=6bb05220362, createdName=小括号, createdTime=Mon Jan 17 20:42:41 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-02-17 14623ca2m59暂无昵称

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1196718, encodeId=b4241196e18b5, content=有没有中文版的呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6c5608723, createdName=芳芳要加油呀, createdTime=Thu Feb 24 09:53:25 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194596, encodeId=a4131194596d9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/wXBRnlwuk4va3vboNhiadEuDicEMibKT4WpgCkeG6CLw3kPCm1pqMMRYUZTqTXQzbgcKbaSYsQia2BTZW3U1uYqicGA/132, createdBy=03805115270, createdName=14623ca2m59暂无昵称, createdTime=Thu Feb 17 21:20:23 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185320, encodeId=3b5d118532013, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f94874946, createdName=tyiutyu16, createdTime=Mon Jan 17 20:55:05 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185314, encodeId=92e3118531450, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210729/5d08785c686c4387943d27b2b4a7bf7d/b011876b7af14bacb5649749c0c6192a.jpg, createdBy=6bb05220362, createdName=小括号, createdTime=Mon Jan 17 20:42:41 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-01-17 tyiutyu16

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1196718, encodeId=b4241196e18b5, content=有没有中文版的呀, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ae6c5608723, createdName=芳芳要加油呀, createdTime=Thu Feb 24 09:53:25 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194596, encodeId=a4131194596d9, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/wXBRnlwuk4va3vboNhiadEuDicEMibKT4WpgCkeG6CLw3kPCm1pqMMRYUZTqTXQzbgcKbaSYsQia2BTZW3U1uYqicGA/132, createdBy=03805115270, createdName=14623ca2m59暂无昵称, createdTime=Thu Feb 17 21:20:23 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185320, encodeId=3b5d118532013, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=84f94874946, createdName=tyiutyu16, createdTime=Mon Jan 17 20:55:05 CST 2022, time=2022-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1185314, encodeId=92e3118531450, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210729/5d08785c686c4387943d27b2b4a7bf7d/b011876b7af14bacb5649749c0c6192a.jpg, createdBy=6bb05220362, createdName=小括号, createdTime=Mon Jan 17 20:42:41 CST 2022, time=2022-01-17, status=1, ipAttribution=)]
    2022-01-17 小括号

    学习

    0

Baidu
map
Baidu
map
Baidu
map